Target Name: OR5K2
NCBI ID: G402135
Review Report on OR5K2 Target / Biomarker Content of Review Report on OR5K2 Target / Biomarker
OR5K2
Other Name(s): olfactory receptor family 5 subfamily K member 2 | Olfactory receptor family 5 subfamily K member 2 | OR5K2_HUMAN | OR3-9 | Olfactory receptor OR3-9 | Olfactory receptor 5K2 | olfactory receptor OR3-9

Potential Drug Target for OR5K2

OR5K2 (Olfactory Receptor Family 5 Subfamily K Member 2) is a protein that is expressed in the olfactory system, which is responsible for the sense of smell. OR5K2 plays a crucial role in this system, as it is involved in the development and maintenance of the sensory neurons that carry the sense of smell from the nose and mouth to the brain.

Recent studies have identified OR5K2 as a potential drug target for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because the olfactory system is one of the most sensitive systems in the body, and disruptions in its function can have a significant impact on a person's quality of life.

One of the key reasons for the potential of OR5K2 as a drug target is its involvement in the development and maintenance of sensory neurons. Olfactory neurons are responsible for transmitting the sense of smell to the brain, and defects in their development or function can lead to a range of disorders, including Alzheimer's disease, Parkinson's disease, and blindness.

In addition, OR5K2 has been shown to play a role in the regulation of olfactory neuron survival and differentiation. Studies have shown that exposure to environmental toxins, such as cadmium and lead, can cause damage to olfactory neurons and disrupt their function. OR5K2 has also been shown to be involved in the regulation of neuron survival and differentiation in response to these toxins.

Another potential drug target for OR5K2 is its role in the regulation of sensory perception. Sensory perception is a complex process that involves the integration of information from multiple senses, including the sense of smell. OR5K2 has been shown to be involved in the regulation of sensory perception by controlling the release of sensory neurotransmitters.

In addition, OR5K2 has been shown to play a role in the regulation of pain perception. Pain perception is a complex process that involves the integration of information from multiple senses, including the sense of touch. OR5K2 has been shown to be involved in the regulation of pain perception by controlling the release of pain neurotransmitters.

Recent studies have also identified OR5K2 as a potential drug target for several other diseases, including cancer and neurodegenerative diseases. For example, studies have shown that high levels of OR5K2 expression are associated with poor prognosis in patients with pancreatic cancer, a leading cause of cancer-related deaths.

In addition, OR5K2 has been shown to be involved in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have shown that OR5K2 is involved in the regulation of the aggregation of beta-amyloid particles, a hallmark of neurodegenerative disease.

In conclusion, OR5K2 is a protein that is involved in the olfactory system, which is responsible for the sense of smell. Recent studies have identified OR5K2 as a potential drug target for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The Olfactory Receptor Family 5 Subfamily K Member 2 is a promising target for future drug development.

Protein Name: Olfactory Receptor Family 5 Subfamily K Member 2

Functions: Odorant receptor

The "OR5K2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR5K2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5